These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
643 related articles for article (PubMed ID: 26352473)
1. Structure of the toxic core of α-synuclein from invisible crystals. Rodriguez JA; Ivanova MI; Sawaya MR; Cascio D; Reyes FE; Shi D; Sangwan S; Guenther EL; Johnson LM; Zhang M; Jiang L; Arbing MA; Nannenga BL; Hattne J; Whitelegge J; Brewster AS; Messerschmidt M; Boutet S; Sauter NK; Gonen T; Eisenberg DS Nature; 2015 Sep; 525(7570):486-90. PubMed ID: 26352473 [TBL] [Abstract][Full Text] [Related]
2. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases. Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499 [TBL] [Abstract][Full Text] [Related]
3. α-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils. Dearborn AD; Wall JS; Cheng N; Heymann JB; Kajava AV; Varkey J; Langen R; Steven AC J Biol Chem; 2016 Jan; 291(5):2310-8. PubMed ID: 26644467 [TBL] [Abstract][Full Text] [Related]
4. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy. Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316 [TBL] [Abstract][Full Text] [Related]
5. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Tuttle MD; Comellas G; Nieuwkoop AJ; Covell DJ; Berthold DA; Kloepper KD; Courtney JM; Kim JK; Barclay AM; Kendall A; Wan W; Stubbs G; Schwieters CD; Lee VM; George JM; Rienstra CM Nat Struct Mol Biol; 2016 May; 23(5):409-15. PubMed ID: 27018801 [TBL] [Abstract][Full Text] [Related]
6. Cryo-EM structure of alpha-synuclein fibrils. Guerrero-Ferreira R; Taylor NM; Mona D; Ringler P; Lauer ME; Riek R; Britschgi M; Stahlberg H Elife; 2018 Jul; 7():. PubMed ID: 29969391 [TBL] [Abstract][Full Text] [Related]
7. Characterization of fibrillation process of alpha-synuclein at the initial stage. Tashiro M; Kojima M; Kihara H; Kasai K; Kamiyoshihara T; Uéda K; Shimotakahara S Biochem Biophys Res Commun; 2008 May; 369(3):910-4. PubMed ID: 18329380 [TBL] [Abstract][Full Text] [Related]
8. Preparation of α-Synuclein Amyloid Assemblies for Toxicity Experiments. Chen SW; Cremades N Methods Mol Biol; 2018; 1779():45-60. PubMed ID: 29886526 [TBL] [Abstract][Full Text] [Related]
9. Covalent α-synuclein dimers: chemico-physical and aggregation properties. Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053 [TBL] [Abstract][Full Text] [Related]
10. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. Guerrero-Ferreira R; Taylor NM; Arteni AA; Kumari P; Mona D; Ringler P; Britschgi M; Lauer ME; Makky A; Verasdonck J; Riek R; Melki R; Meier BH; Böckmann A; Bousset L; Stahlberg H Elife; 2019 Dec; 8():. PubMed ID: 31815671 [TBL] [Abstract][Full Text] [Related]
11. Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel. Li B; Ge P; Murray KA; Sheth P; Zhang M; Nair G; Sawaya MR; Shin WS; Boyer DR; Ye S; Eisenberg DS; Zhou ZH; Jiang L Nat Commun; 2018 Sep; 9(1):3609. PubMed ID: 30190461 [TBL] [Abstract][Full Text] [Related]
12. Structural analyses and force fields comparison for NACore (68-78) and SubNACore (69-77) fibril segments of Parkinson's disease. Alıcı H J Mol Model; 2020 May; 26(6):132. PubMed ID: 32394304 [TBL] [Abstract][Full Text] [Related]
13. Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue. Dhavale DD; Barclay AM; Borcik CG; Basore K; Berthold DA; Gordon IR; Liu J; Milchberg MH; O'Shea JY; Rau MJ; Smith Z; Sen S; Summers B; Smith J; Warmuth OA; Perrin RJ; Perlmutter JS; Chen Q; Fitzpatrick JAJ; Schwieters CD; Tajkhorshid E; Rienstra CM; Kotzbauer PT Nat Commun; 2024 Mar; 15(1):2750. PubMed ID: 38553463 [TBL] [Abstract][Full Text] [Related]
14. Amphiphilic surface chemistry of fullerenols is necessary for inhibiting the amyloid aggregation of alpha-synuclein NACore. Sun Y; Kakinen A; Zhang C; Yang Y; Faridi A; Davis TP; Cao W; Ke PC; Ding F Nanoscale; 2019 Jun; 11(24):11933-11945. PubMed ID: 31188372 [TBL] [Abstract][Full Text] [Related]
15. The fold of alpha-synuclein fibrils. Vilar M; Chou HT; Lührs T; Maji SK; Riek-Loher D; Verel R; Manning G; Stahlberg H; Riek R Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8637-42. PubMed ID: 18550842 [TBL] [Abstract][Full Text] [Related]
16. Modulating α-synuclein fibril formation using DNA tetrahedron nanostructures. Yoo WK; Ryu BH; Kim KR; Wang Y; Le LTHL; Lee JH; Kim KK; Toth G; Ahn DR; Doohun Kim T Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):73-81. PubMed ID: 30278239 [TBL] [Abstract][Full Text] [Related]
18. Structures of segments of α-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formation. Zhao M; Cascio D; Sawaya MR; Eisenberg D Protein Sci; 2011 Jun; 20(6):996-1004. PubMed ID: 21462277 [TBL] [Abstract][Full Text] [Related]
19. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Chen SW; Drakulic S; Deas E; Ouberai M; Aprile FA; Arranz R; Ness S; Roodveldt C; Guilliams T; De-Genst EJ; Klenerman D; Wood NW; Knowles TP; Alfonso C; Rivas G; Abramov AY; Valpuesta JM; Dobson CM; Cremades N Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E1994-2003. PubMed ID: 25855634 [TBL] [Abstract][Full Text] [Related]
20. α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly. Oikawa T; Nonaka T; Terada M; Tamaoka A; Hisanaga S; Hasegawa M J Biol Chem; 2016 Jul; 291(29):15046-56. PubMed ID: 27226637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]